MedTrace Logo

Clinical Explorative Optical Breast Investigations

NCT06857669 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-04-29

No results posted yet for this study

Summary

This study evaluates diffuse reflectance spectroscopy and photoacoustic imaging for differentiating healthy, benign, and malignant breast tissue by identifying their optical profiles.

Conditions

  • Benign Breast Tumors
  • Malignant Breast Tumours
  • Healthy

Interventions

DIAGNOSTIC_TEST

Diffuse reflectance spectroscopy and Photoacoustic imaging,

The photoacoustic imaging/diffuse reflectance spectroscopy techniques used in this study have a broader wavelength spectrum. The photoacoustic set-up can generate an optical and an ultrasound image simultaneously.

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Unilabs

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Principal Investigators

  • Sophia Zackrisson, MD, PhD · Region Skane, Lund University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2026-12-31
Completion
2027-05-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06857669 on ClinicalTrials.gov